There was no statistical significance between the infectious agent and the macroscopic image and diagnosis in the Bethesda system
The distribution of cytological diagnoses of the biopsyproven cases of PTC, according to the six categories of the Bethesda system
of reporting thyroid cytopathology was done as follows: 6 cases were (8%) nondiagnostic, 3 (4%) benign, 0 (0%) AUS/FLUS, 2 (2.
The Bethesda System
for Reporting Cervical/Vaginal Cytologic Diagnoses.
Review of atypical cytology of thyroid nodule according to the Bethesda system
and its beneficial effect in the surgical treatment of papillary carcinoma.
The Bethesda System
of reporting was used for all smears, and specimen adequacy was designated satisfactory for evaluation'" "satisfactory but limited," or "unsatisfactory" based on standard criteria.
Rapid communication: the Bethesda System
for reporting cervical/vaginal cytologic diagnoses--report of the 1991 Bethesda Workshop.
The FDA approval was based on the results of a multi-site trial designed to evaluate the routine screening of ThinPrep Pap Test slides using the ThinPrep Imaging System compared to a manual review of ThinPrep Pap Test slides for all categories used for cytologic diagnosis (specimen adequacy and descriptive diagnosis) as defined by the Bethesda System
By the publication and acceptance of what has become known as the Bethesda System
for Reporting Thyroid Cytopathology (BSRTC), it was hoped that there would be more effective communication among provider stakeholders, greater facilitation of cytologic-histologic correlations, and the easy and reliable sharing of data between different laboratories.
In: The Bethesda System
for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes, 2nd edn.
24) which was conducted on 731 and 268 cases respectively, also showed that by adopting the Bethesda system
of reporting a higher level of sensitivity (99.
The Bethesda system
recommends categorisation of results into six categories; I: inadequate; II: benign; III: atypical follicular cells of undetermined significance (FLUS); IV: follicular neoplasm (FN); V: suspicious for malignancy; and VI: malignant.
In 1988, the cytological classification with a multi-stage assessment according to the Bethesda System